An examination of the current state of pharmacovigilance and postmarketing surveillance programs in the United States and potential solutions for improvement
An examination of the current state of pharmacovigilance and postmarketing surveillance programs in the United States and potential solutions for improvement
IO_a6ac78e5-952b-4698-8605-c1bd0193b0bc
Are current federal regulations on OTC drug products sufficient to control nation-wide methamphetamine issues?
IO_f3211026-20fa-44d3-8ff3-65e50f6b782c
Can China be a viable biosimilars entry market as compared with the US?
IO_e460dc8d-e98b-46f5-a4b7-95c325cdb99d
Mixed effects modeling of tranexamic acid in pediatric patients
IO_a30d17e0-4a19-40b0-aa6c-77516bb177df
Orphan drug market developments in the US and EU
IO_f7abfec1-6ad2-4c87-bad4-bca18517e304
Pediatric medicinal product research and development
IO_f4fefbef-1165-40a5-a71e-aef23400a447
We use cookies so that we can provide you with the best user experience possible. Click Accept to confirm that you are happy with us to use cookies.